Press Releases GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.19 ^USD	+1.55%		+7.47%	+7.31%

Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 10	KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX	Apr. 26	PR
GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP	Apr. 26	PR
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX	Apr. 25	NE
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit	Apr. 25	BU
GDRX Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	Apr. 25	PR
GoodRx Announces Date for 2024 Investor Day	Apr. 24	BU
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx	Apr. 23	PR
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX	Apr. 23	BU
GDRX Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm	Apr. 22	BU
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call	Apr. 11	BU
GoodRx Interim CEO Extends Commitment to Company	Mar. 14	BU
GoodRx Reports Fourth Quarter and Full Year 2023 Results	Feb. 29	BU
Key Pitfalls To Avoid When Using Tracking Technologies For DTC Digital Health And Telemedicine Performance Marketing	Feb. 22	AQ
GoodRx to Participate in Upcoming Investor Conferences	Feb. 20	BU
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call	Feb. 01	BU
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities	Jan. 22	BU
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings	Jan. 11	BU
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024	Jan. 10	BU
GoodRx Appoints Kelly J. Kennedy to Board of Directors	Dec. 22	BU
Amino Health Announces John Asalone as New CEO, David Vivero Assumes Role of Chairman in CEO Succession	Dec. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Press Releases

Filters